FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes
PMA: P960013
·
Supplement: S124
·
Decision Mar 26, 2024
Classifications
1
FEI Numbers
26
Registration Numbers
26
Basic Information
- Device Name
- Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes
- Trade Name
- Tendril STS, UltiPace
- PMA Number
- P960013
- Supplement Number
- S124
- Device Class
- FDA Class 3
- Product Code
- NVN
- Generic Name
- Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- March 26, 2024
- Date Received
- January 2, 2024
- Supplement Type
- Real-Time Process
- Supplement Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Expedited Review
- N
Advisory Committee Statement
expansion of MR Conditional labeling of Endurity MRI and Assurity MRI pacemakers with Tendril STS 2088TC or UltiPace LPA1231 bradycardia leads placed in the left bundle branch area
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NVN | Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes | FDA class 3 | Unknown |